Related Articles
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
BIIB021, an Hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review)
Effects of treatment with an Hsp90 inhibitor in tumors based on 15 phase II clinical trials
HSP90 and its inhibitors (Review)
Preclinical antitumor activity of SST0116CL1: A novel heat shock protein 90 inhibitor